Literature DB >> 9618505

Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma.

J G Herman1, A Umar, K Polyak, J R Graff, N Ahuja, J P Issa, S Markowitz, J K Willson, S R Hamilton, K W Kinzler, M F Kane, R D Kolodner, B Vogelstein, T A Kunkel, S B Baylin.   

Abstract

Inactivation of the genes involved in DNA mismatch repair is associated with microsatellite instability (MSI) in colorectal cancer. We report that hypermethylation of the 5' CpG island of hMLH1 is found in the majority of sporadic primary colorectal cancers with MSI, and that this methylation was often, but not invariably, associated with loss of hMLH1 protein expression. Such methylation also occurred, but was less common, in MSI- tumors, as well as in MSI+ tumors with known mutations of a mismatch repair gene (MMR). No hypermethylation of hMSH2 was found. Hypermethylation of colorectal cancer cell lines with MSI also was frequently observed, and in such cases, reversal of the methylation with 5-aza-2'-deoxycytidine not only resulted in reexpression of hMLH1 protein, but also in restoration of the MMR capacity in MMR-deficient cell lines. Our results suggest that microsatellite instability in sporadic colorectal cancer often results from epigenetic inactivation of hMLH1 in association with DNA methylation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9618505      PMCID: PMC22665          DOI: 10.1073/pnas.95.12.6870

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Wet autoclave pretreatment for antigen retrieval in diagnostic immunohistochemistry.

Authors:  A Bankfalvi; H Navabi; B Bier; W Böcker; B Jasani; K W Schmid
Journal:  J Pathol       Date:  1994-11       Impact factor: 7.996

2.  Mismatch repair defects and O6-methylguanine-DNA methyltransferase expression in acquired resistance to methylating agents in human cells.

Authors:  R Hampson; O Humbert; P Macpherson; G Aquilina; P Karran
Journal:  J Biol Chem       Date:  1997-11-07       Impact factor: 5.157

3.  Defective mismatch repair in extracts of colorectal and endometrial cancer cell lines exhibiting microsatellite instability.

Authors:  A Umar; J C Boyer; D C Thomas; D C Nguyen; J I Risinger; J Boyd; Y Ionov; M Perucho; T A Kunkel
Journal:  J Biol Chem       Date:  1994-05-20       Impact factor: 5.157

4.  Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability.

Authors:  B Liu; N C Nicolaides; S Markowitz; J K Willson; R E Parsons; J Jen; N Papadopolous; P Peltomäki; A de la Chapelle; S R Hamilton
Journal:  Nat Genet       Date:  1995-01       Impact factor: 38.330

5.  Microsatellite instability in cancer of the proximal colon.

Authors:  S N Thibodeau; G Bren; D Schaid
Journal:  Science       Date:  1993-05-07       Impact factor: 47.728

6.  Clues to the pathogenesis of familial colorectal cancer.

Authors:  L A Aaltonen; P Peltomäki; F S Leach; P Sistonen; L Pylkkänen; J P Mecklin; H Järvinen; S M Powell; J Jen; S R Hamilton
Journal:  Science       Date:  1993-05-07       Impact factor: 47.728

7.  Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer.

Authors:  A Hemminki; P Peltomäki; J P Mecklin; H Järvinen; R Salovaara; M Nyström-Lahti; A de la Chapelle; L A Aaltonen
Journal:  Nat Genet       Date:  1994-12       Impact factor: 38.330

8.  Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.

Authors:  J G Herman; F Latif; Y Weng; M I Lerman; B Zbar; S Liu; D Samid; D S Duan; J R Gnarra; W M Linehan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

9.  Cell culture of human colon adenomas and carcinomas.

Authors:  J K Willson; G N Bittner; T D Oberley; L F Meisner; J L Weese
Journal:  Cancer Res       Date:  1987-05-15       Impact factor: 12.701

10.  Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability.

Authors:  S Markowitz; J Wang; L Myeroff; R Parsons; L Sun; J Lutterbaugh; R S Fan; E Zborowska; K W Kinzler; B Vogelstein
Journal:  Science       Date:  1995-06-02       Impact factor: 47.728

View more
  509 in total

1.  Genetic instability and the mutator phenotype. Studies in ulcerative colitis.

Authors:  K R Loeb; L A Loeb
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

2.  Carcinogen-specific induction of genetic instability.

Authors:  A Bardelli; D P Cahill; G Lederer; M R Speicher; K W Kinzler; B Vogelstein; C Lengauer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

3.  Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia.

Authors:  F Magdinier; A P Wolffe
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

Review 4.  DNA mismatch repair genes and colorectal cancer.

Authors:  J M Wheeler; W F Bodmer; N J Mortensen
Journal:  Gut       Date:  2000-07       Impact factor: 23.059

Review 5.  Epigenetic gene silencing in cancer.

Authors:  B Tycko
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

6.  Cancer epigenetics takes center stage.

Authors:  A P Feinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205

Review 7.  Chromatin modification and disease.

Authors:  C A Johnson
Journal:  J Med Genet       Date:  2000-12       Impact factor: 6.318

8.  Regulation of DNA methylation of Rasgrf1.

Authors:  Bong June Yoon; Herry Herman; Aimee Sikora; Laura T Smith; Christoph Plass; Paul D Soloway
Journal:  Nat Genet       Date:  2001-12-20       Impact factor: 38.330

9.  Genetic and epigenetic modification of MLH1.

Authors:  M Perucho
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

10.  hMLH1 promoter hypermethylation in microsatellite instability-positive endometrial carcinoma. Cause or consequence?

Authors:  L H Ellenson
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.